S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
The Retirement of Your Dreams Awaits You… (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
The Retirement of Your Dreams Awaits You… (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Closing prices for crude oil, gold and other commodities
Better Than Oil Stocks (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Mike Tyson’s Wisdom: Life, Planning, and Resilience
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
The Retirement of Your Dreams Awaits You… (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
The Retirement of Your Dreams Awaits You… (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Closing prices for crude oil, gold and other commodities
Better Than Oil Stocks (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Mike Tyson’s Wisdom: Life, Planning, and Resilience
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
The Retirement of Your Dreams Awaits You… (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
The Retirement of Your Dreams Awaits You… (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Closing prices for crude oil, gold and other commodities
Better Than Oil Stocks (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Mike Tyson’s Wisdom: Life, Planning, and Resilience
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
The Retirement of Your Dreams Awaits You… (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
The Retirement of Your Dreams Awaits You… (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Closing prices for crude oil, gold and other commodities
Better Than Oil Stocks (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Mike Tyson’s Wisdom: Life, Planning, and Resilience

Cognition Therapeutics (CGTX) News Today

$2.00
-0.01 (-0.50%)
(As of 02/23/2024 ET)
SourceHeadline
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Olema Pharmaceuticals (OLMA), IDEAYA Biosciences (IDYA)
markets.businessinsider.com - February 22 at 2:04 PM
MarketBeat logoCognition Therapeutics, Inc. (NASDAQ:CGTX) Short Interest Up 24.0% in January
americanbankingnews.com - February 16 at 2:16 AM
finanznachrichten.de logoCognition Therapeutics, Inc.: New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812
finanznachrichten.de - February 6 at 2:12 PM
finance.yahoo.com logoNew Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812
finance.yahoo.com - February 6 at 9:11 AM
msn.com logoStudy suggests how cognitive behavioral therapy changes brain activity in children with anxiety
msn.com - February 1 at 9:10 PM
finance.yahoo.com logoHere's Why We're Watching Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Situation
finance.yahoo.com - January 16 at 2:48 PM
msn.com logoDigital CBT intervention reduces anxiety and improves quality of life for pulmonary fibrosis patients
msn.com - January 8 at 8:06 AM
finanznachrichten.de logoCognition Therapeutics, Inc.: Cognition Therapeutics CEO Issues Letter to Shareholders
finanznachrichten.de - January 4 at 11:21 AM
finance.yahoo.com logoCognition Therapeutics CEO Issues Letter to Shareholders
finance.yahoo.com - January 4 at 11:21 AM
msn.com logoCognition Therapeutics files to sell 6.03M shares for holders
msn.com - December 29 at 6:13 PM
morningstar.com logoCognition Therapeutics Inc CGTX
morningstar.com - November 22 at 9:26 AM
finance.yahoo.com logoCognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip Scheltens
finance.yahoo.com - November 16 at 10:15 AM
stockhouse.com logoCognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer's and Parkinson's Diseases
stockhouse.com - November 15 at 1:13 PM
finance.yahoo.com logoCognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s Diseases
finance.yahoo.com - November 15 at 8:13 AM
benzinga.com logoCognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease
benzinga.com - November 7 at 8:49 AM
finance.yahoo.com logoCognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease
finance.yahoo.com - November 7 at 8:49 AM
finance.yahoo.com logoCognition Therapeutics Inc (CGTX) Reports Q3 2023 Financial Results
finance.yahoo.com - November 3 at 8:58 AM
msn.com logoCognition Therapeutics GAAP EPS of $0.22 beats by $0.46
msn.com - November 2 at 12:35 PM
finance.yahoo.com logoCognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - November 2 at 12:35 PM
finance.yahoo.com logoCognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation on the START Study in Early Alzheimer’s Disease at CTAD
finance.yahoo.com - October 27 at 12:48 PM
stockhouse.com logoCognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer's Disease at CTAD
stockhouse.com - October 24 at 7:49 PM
finance.yahoo.com logoCognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at CTAD
finance.yahoo.com - October 24 at 7:49 PM
finance.yahoo.com logoCognition Therapeutics Presents New Data at CTAD Conference from Advancing Pipeline Across Multiple CNS Indications
finance.yahoo.com - October 16 at 2:47 PM
thestreet.com logoCognition Therapeutics Inc.
thestreet.com - September 27 at 3:39 PM
finance.yahoo.com logoCognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMD
finance.yahoo.com - September 7 at 8:07 AM
finance.yahoo.com logoCognition Therapeutics Announces Participation in Upcoming September Conferences
finance.yahoo.com - August 30 at 8:22 AM
msn.com logoLadenburg Thalmann Maintains Cognition Therapeutics (CGTX) Buy Recommendation
msn.com - August 14 at 6:28 PM
finance.yahoo.com logoWill Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely?
finance.yahoo.com - August 9 at 10:52 AM
finance.yahoo.com logoQ2 2023 Cognition Therapeutics Inc Earnings Call
finance.yahoo.com - August 9 at 1:17 AM
finanznachrichten.de logoCognition Therapeutics, Inc.: Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
finanznachrichten.de - August 8 at 10:16 AM
finance.yahoo.com logoCognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
finance.yahoo.com - August 8 at 10:16 AM
benzinga.com logoCognition Therapeutics's Earnings Outlook
benzinga.com - August 8 at 10:16 AM
finance.yahoo.com logoCognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
finance.yahoo.com - August 8 at 10:16 AM
finance.yahoo.com logoCognition Therapeutics to Report Second Quarter 2023 Results in Conference Call on Tuesday, August 8, 2023
finance.yahoo.com - August 2 at 10:24 AM
finance.yahoo.com logoCognition Therapeutics Announces Dosing of First Patient in MAGNIFY Study of Oral CT1812 for Geographic Atrophy Secondary to Dry AMD
finance.yahoo.com - July 11 at 9:52 AM
finance.yahoo.com logoCognition Therapeutics and the Alzheimer's Clinical Trials Consortium Initiate First Clinical Site in the Phase 2 START Study in Early Alzheimer’s Disease
finance.yahoo.com - July 5 at 8:51 AM
msn.com logoWhy Cognition Therapeutics Stock Is Plunging On Alzheimer's Disease Related News Today
msn.com - June 28 at 3:54 PM
msn.com logoCognition drops 12% after mid-stage data for Alzheimer’s candidate
msn.com - June 28 at 3:54 PM
markets.businessinsider.com logoCognition Reports Positive Topline Results For CT1812 Phase 2 SEQUEL Study For Alzheimer's Disease
markets.businessinsider.com - June 28 at 9:27 AM
finance.yahoo.com logoCognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
finance.yahoo.com - June 28 at 9:27 AM
finance.yahoo.com logoCognition Therapeutics to Host Call and Webcast to Discuss Topline Results from CT1812 Phase 2 SEQUEL Study on June 28, 2023
finance.yahoo.com - June 27 at 11:42 PM
markets.businessinsider.com logoRemember To Check Cognition Stock
markets.businessinsider.com - June 26 at 8:51 AM
finance.yahoo.com logoCognition Therapeutics Invited to Participate on Panel During Cantor Fitzgerald Brain Week 2023 on Novel Alzheimer’s Disease Approaches
finance.yahoo.com - June 20 at 10:51 AM
marketbeat.com logo
marketbeat.com - June 20 at 9:32 AM
finance.yahoo.com logoCognition Therapeutics Continues Investor Engagement in June with Presentations at World Medical Innovation and Longwood Healthcare Leaders Conferences
finance.yahoo.com - June 2 at 11:10 AM
finance.yahoo.com logoIs Accelerate Diagnostics (AXDX) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 23 at 2:15 PM
finance.yahoo.com logoCognition Therapeutics Latest Episode of “Conversations” Podcast Features Biomarker Experts from Gothenburg University, Emory and Amsterdam UMC
finance.yahoo.com - May 23 at 9:14 AM
msn.com logoCognition Therapeutics Explodes Upward on Alzheimer’s Treatment
msn.com - May 18 at 8:36 PM
msn.com logoA Dose of Hope: Cognition's CT1812 Proves Its Mettle in Alzheimer's Aβ Oligomer Displacement
msn.com - May 18 at 3:36 PM
seekingalpha.com logoCognition Therapeutics stock rises after CT1812 shows promise in Alzheimer’s study
seekingalpha.com - May 18 at 3:36 PM
Get Cognition Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGTX and its competitors with MarketBeat's FREE daily newsletter.



CGTX Media Mentions By Week

CGTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CGTX
News Sentiment

0.00

0.43

Average
Medical
News Sentiment

CGTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CGTX Articles
This Week

1

1

CGTX Articles
Average Week

Get Cognition Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CGTX) was last updated on 2/24/2024 by MarketBeat.com Staff